Phase II trial evaluates DCE-US to monitor response to TKI-258 therapy in renal cell carcinoma Sep. 26, 2011
Phase I data on Ad26.ENVA.01 in HAdV-26-seronegative and -seropositive HIV-1-uninfected adults Sep. 23, 2011
RSS